ISSN: 1838-7640Theranostics
- Current issue
- Volume 14; 2024
- Volume 13; 2023
- Volume 12; 2022
- Volume 11; 2021
- Volume 10; 2020
- Archive
- Advance articles
- Cover images
- Index & coverage
- Cover suggestion
- Special issues
Nanotheranostics 2024; 8(4): 442-457. [Abstract] [Full text] [PDF]
Nanotheranostics 2024; 8(4): 427-441. [Abstract] [Full text] [PDF]
International Journal of Biological Sciences
International Journal of Medical Sciences
Global reach, higher impact
Theranostics 2020; 10(12):5528-5529. doi:10.7150/thno.46029 This issue Cite
Erratum
Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
1. State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
2. Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
Citation:
Li F, Li X, Li Z, Ji W, Lu S, Xia W. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2020; 10(12):5528-5529. doi:10.7150/thno.46029. https://www.thno.org/v10p5528.htm
Other stylesCorrected-article in Theranostics, Volume 9, 7474
Citation styles
APA
Li, F., Li, X., Li, Z., Ji, W., Lu, S., Xia, W. (2020). Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics, 10(12), 5528-5529. https://doi.org/10.7150/thno.46029.
ACS
Li, F.; Li, X.; Li, Z.; Ji, W.; Lu, S.; Xia, W. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2020, 10 (12), 5528-5529. DOI: 10.7150/thno.46029.
NLM
Li F, Li X, Li Z, Ji W, Lu S, Xia W. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2020; 10(12):5528-5529. doi:10.7150/thno.46029. https://www.thno.org/v10p5528.htm
CSE
Li F, Li X, Li Z, Ji W, Lu S, Xia W. 2020. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics. 10(12):5528-5529.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
